{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,17]],"date-time":"2026-08-17T21:51:32Z","timestamp":1787003492421,"version":"build-2736575974"},"reference-count":51,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2020,10,22]],"date-time":"2020-10-22T00:00:00Z","timestamp":1603324800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2020,10,22]],"date-time":"2020-10-22T00:00:00Z","timestamp":1603324800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/100010815","name":"Stiftelsen f\u00f6r Gamla Tj\u00e4narinnor","doi-asserted-by":"crossref","id":[{"id":"10.13039\/100010815","id-type":"DOI","asserted-by":"crossref"}]},{"name":"Herbert och Karin Jacobssons Stiftelse"},{"DOI":"10.13039\/100009673","name":"Gun och Bertil Stohnes Stiftelse","doi-asserted-by":"crossref","id":[{"id":"10.13039\/100009673","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/501100003792","name":"Hj\u00e4rnfonden","doi-asserted-by":"crossref","award":["FO2019-0006"],"award-info":[{"award-number":["FO2019-0006"]}],"id":[{"id":"10.13039\/501100003792","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/501100003792","name":"Hj\u00e4rnfonden","doi-asserted-by":"crossref","award":["FO2017-0243"],"award-info":[{"award-number":["FO2017-0243"]}],"id":[{"id":"10.13039\/501100003792","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/501100003748","name":"Svenska S\u00e4llskapet f\u00f6r Medicinsk Forskning","doi-asserted-by":"crossref","id":[{"id":"10.13039\/501100003748","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/501100004359","name":"Swedish Research Council","doi-asserted-by":"crossref","award":["2018-02532"],"award-info":[{"award-number":["2018-02532"]}],"id":[{"id":"10.13039\/501100004359","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/501100004359","name":"Swedish Research Council","doi-asserted-by":"crossref","award":["2017-00915"],"award-info":[{"award-number":["2017-00915"]}],"id":[{"id":"10.13039\/501100004359","id-type":"DOI","asserted-by":"crossref"}]},{"name":"European Research Council","award":["681712"],"award-info":[{"award-number":["681712"]}]},{"name":"Swedish State Support for Clinical Research","award":["ALFGBG-720931"],"award-info":[{"award-number":["ALFGBG-720931"]}]},{"name":"UK Dementia Research Institute at UCL"},{"DOI":"10.13039\/100002565","name":"Alzheimer's Drug Discovery Foundation","doi-asserted-by":"crossref","award":["RDAPB-201809-2016615"],"award-info":[{"award-number":["RDAPB-201809-2016615"]}],"id":[{"id":"10.13039\/100002565","id-type":"DOI","asserted-by":"crossref"}]},{"name":"Swedish Alzheimer Foundation","award":["AF-742881"],"award-info":[{"award-number":["AF-742881"]}]},{"name":"Swedish state under the agreement between the Swedish government and the County Councils"},{"name":"ALF-agreement","award":["ALFGBG-715986"],"award-info":[{"award-number":["ALFGBG-715986"]}]},{"name":"European Union Joint Program for Neurodegenerative Disorders","award":["JPND2019-466-236"],"award-info":[{"award-number":["JPND2019-466-236"]}]},{"name":"Gothenburg University Library"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Sci Rep"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>Matrix metalloproteinases (MMPs) are extracellular enzymes involved in the degradation of extracellular matrix (ECM) proteins. Increased expression of MMPs have been described in traumatic brain injury (TBI) and may contribute to additional tissue injury and blood\u2013brain barrier damage. The objectives of this study were to determine longitudinal changes in cerebrospinal fluid (CSF) concentrations of MMPs after acute TBI and in relation to clinical outcomes, with patients with idiopathic normal pressure hydrocephalus (iNPH) serving as a contrast group. The study included 33 TBI patients with ventricular CSF serially sampled, and 38 iNPH patients in the contrast group. Magnetic bead-based immunoassays were utilized to measure the concentrations of eight MMPs in ventricular human CSF. CSF concentrations of MMP-1, MMP-3 and MMP-10 were increased in TBI patients (at baseline) compared with the iNPH group (p\u2009&lt;\u20090.001), while MMP-2, MMP-9 and MMP-12 did not differ between the groups. MMP-1, MMP-3 and MMP-10 concentrations decreased with time after trauma (p\u2009=\u20090.001\u20130.04). Increased concentrations of MMP-2 and MMP-10 in CSF at baseline were associated with an unfavourable TBI outcome (p\u2009=\u20090.002\u20130.02). Observed variable pattern of changes in MMP concentrations indicates that specific MMPs serve different roles in the pathophysiology following TBI, and are in turn associated with clinical outcomes.<\/jats:p>","DOI":"10.1038\/s41598-020-75233-z","type":"journal-article","created":{"date-parts":[[2020,10,22]],"date-time":"2020-10-22T06:03:14Z","timestamp":1603346594000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":33,"title":["Dynamics of cerebrospinal fluid levels of matrix metalloproteinases in human traumatic brain injury"],"prefix":"10.1038","volume":"10","author":[{"given":"Karolina","family":"Minta","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gunnar","family":"Brinkmalm","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Faiez","family":"Al Nimer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eric P.","family":"Thelin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fredrik","family":"Piehl","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mats","family":"Tullberg","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anna","family":"Jeppsson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Erik","family":"Portelius","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Henrik","family":"Zetterberg","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kaj","family":"Blennow","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ulf","family":"Andreasson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2020,10,22]]},"reference":[{"key":"75233_CR1","doi-asserted-by":"publisher","first-page":"e110905","DOI":"10.1371\/journal.pone.0110905","volume":"9","author":"AC Scholten","year":"2014","unstructured":"Scholten, A. C., Haagsma, J. A., Panneman, M. J., van Beeck, E. F. & Polinder, S. Traumatic brain injury in the Netherlands: Incidence, costs and disability-adjusted life years. PLoS ONE 9, e110905. https:\/\/doi.org\/10.1371\/journal.pone.0110905 (2014).","journal-title":"PLoS ONE"},{"key":"75233_CR2","doi-asserted-by":"publisher","first-page":"65","DOI":"10.1097\/HTR.0b013e318295f590","volume":"29","author":"ME Gubata","year":"2014","unstructured":"Gubata, M. E. et al. Trends in the epidemiology of disability related to traumatic brain injury in the US Army and Marine Corps: 2005 to 2010. J. Head Trauma Rehabil. 29, 65\u201375. https:\/\/doi.org\/10.1097\/HTR.0b013e318295f590 (2014).","journal-title":"J. Head Trauma Rehabil."},{"key":"75233_CR3","doi-asserted-by":"publisher","DOI":"10.3171\/2017.10.JNS17352","author":"MC Dewan","year":"2018","unstructured":"Dewan, M. C. et al. Estimating the global incidence of traumatic brain injury. J. Neurosurg. https:\/\/doi.org\/10.3171\/2017.10.JNS17352 (2018).","journal-title":"J. Neurosurg."},{"key":"75233_CR4","doi-asserted-by":"publisher","first-page":"16084","DOI":"10.1038\/nrdp.2016.84","volume":"2","author":"K Blennow","year":"2016","unstructured":"Blennow, K. et al. Traumatic brain injuries. Nat. Rev. Dis. Primers 2, 16084. https:\/\/doi.org\/10.1038\/nrdp.2016.84 (2016).","journal-title":"Nat. Rev. Dis. Primers"},{"key":"75233_CR5","doi-asserted-by":"publisher","first-page":"491","DOI":"10.3171\/jns.1977.47.4.0491","volume":"47","author":"DP Becker","year":"1977","unstructured":"Becker, D. P. et al. The outcome from severe head injury with early diagnosis and intensive management. J. Neurosurg. 47, 491\u2013502. https:\/\/doi.org\/10.3171\/jns.1977.47.4.0491 (1977).","journal-title":"J. Neurosurg."},{"key":"75233_CR6","doi-asserted-by":"publisher","first-page":"81","DOI":"10.1016\/s0140-6736(74)91639-0","volume":"2","author":"G Teasdale","year":"1974","unstructured":"Teasdale, G. & Jennett, B. Assessment of coma and impaired consciousness. A practical scale. Lancet 2, 81\u201384. https:\/\/doi.org\/10.1016\/s0140-6736(74)91639-0 (1974).","journal-title":"Lancet"},{"key":"75233_CR7","doi-asserted-by":"publisher","first-page":"12","DOI":"10.1007\/bf01400521","volume":"91","author":"JE Starmark","year":"1988","unstructured":"Starmark, J. E., Stalhammar, D. & Holmgren, E. The Reaction Level Scale (RLS85). Manual and guidelines. Acta Neurochir. (Wien) 91, 12\u201320. https:\/\/doi.org\/10.1007\/bf01400521 (1988).","journal-title":"Acta Neurochir. (Wien)"},{"key":"75233_CR8","doi-asserted-by":"publisher","first-page":"1083","DOI":"10.1016\/j.injury.2006.07.009","volume":"37","author":"TA Gennarelli","year":"2006","unstructured":"Gennarelli, T. A. & Wodzin, E. AIS 2005: A contemporary injury scale. Injury 37, 1083\u20131091. https:\/\/doi.org\/10.1016\/j.injury.2006.07.009 (2006).","journal-title":"Injury"},{"issue":"Suppl 1","key":"75233_CR9","first-page":"S287","volume":"9","author":"LF Marshall","year":"1992","unstructured":"Marshall, L. F. et al. The diagnosis of head injury requires a classification based on computed axial tomography. J. Neurotrauma 9(Suppl 1), S287-292 (1992).","journal-title":"J. Neurotrauma"},{"key":"75233_CR10","doi-asserted-by":"publisher","first-page":"1173","DOI":"10.1227\/01.NEU.0000186013.63046.6B","volume":"57","author":"AI Maas","year":"2005","unstructured":"Maas, A. I., Hukkelhoven, C. W., Marshall, L. F. & Steyerberg, E. W. Prediction of outcome in traumatic brain injury with computed tomographic characteristics: A comparison between the computed tomographic classification and combinations of computed tomographic predictors. Neurosurgery 57, 1173\u20131182 (2005) (discussion 1173\u20131182).","journal-title":"Neurosurgery"},{"key":"75233_CR11","doi-asserted-by":"publisher","first-page":"632","DOI":"10.1227\/NEU.0000000000000533","volume":"75","author":"R Raj","year":"2014","unstructured":"Raj, R., Siironen, J., Skrifvars, M. B., Hernesniemi, J. & Kivisaari, R. Predicting outcome in traumatic brain injury: Development of a novel computerized tomography classification system (Helsinki computerized tomography score). Neurosurgery 75, 632\u2013646. https:\/\/doi.org\/10.1227\/NEU.0000000000000533 (2014) (discussion 646\u2013637).","journal-title":"Neurosurgery"},{"key":"75233_CR12","doi-asserted-by":"publisher","first-page":"51","DOI":"10.1089\/neu.2009.0986","volume":"27","author":"DW Nelson","year":"2010","unstructured":"Nelson, D. W. et al. Extended analysis of early computed tomography scans of traumatic brain injured patients and relations to outcome. J. Neurotrauma 27, 51\u201364. https:\/\/doi.org\/10.1089\/neu.2009.0986 (2010).","journal-title":"J. Neurotrauma"},{"key":"75233_CR13","doi-asserted-by":"publisher","first-page":"263","DOI":"10.1007\/s007010170106","volume":"143","author":"R Firsching","year":"2001","unstructured":"Firsching, R. et al. Classification of severe head injury based on magnetic resonance imaging. Acta Neurochir. (Wien) 143, 263\u2013271. https:\/\/doi.org\/10.1007\/s007010170106 (2001).","journal-title":"Acta Neurochir. (Wien)"},{"key":"75233_CR14","doi-asserted-by":"publisher","first-page":"e165","DOI":"10.1371\/journal.pmed.0050165","volume":"5","author":"EW Steyerberg","year":"2008","unstructured":"Steyerberg, E. W. et al. Predicting outcome after traumatic brain injury: Development and international validation of prognostic scores based on admission characteristics. PLoS Med 5, e165. https:\/\/doi.org\/10.1371\/journal.pmed.0050165 (2008) (discussion e165).","journal-title":"PLoS Med"},{"key":"75233_CR15","doi-asserted-by":"publisher","first-page":"480","DOI":"10.1016\/s0140-6736(75)92830-5","volume":"1","author":"B Jennett","year":"1975","unstructured":"Jennett, B. & Bond, M. Assessment of outcome after severe brain damage. Lancet 1, 480\u2013484. https:\/\/doi.org\/10.1016\/s0140-6736(75)92830-5 (1975).","journal-title":"Lancet"},{"key":"75233_CR16","doi-asserted-by":"publisher","first-page":"1277","DOI":"10.1152\/physrev.00027.2007","volume":"88","author":"E Sykova","year":"2008","unstructured":"Sykova, E. & Nicholson, C. Diffusion in brain extracellular space. Physiol. Rev. 88, 1277\u20131340. https:\/\/doi.org\/10.1152\/physrev.00027.2007 (2008).","journal-title":"Physiol. Rev."},{"key":"75233_CR17","doi-asserted-by":"publisher","first-page":"165","DOI":"10.1242\/dmm.004077","volume":"4","author":"TR Cox","year":"2011","unstructured":"Cox, T. R. & Erler, J. T. Remodeling and homeostasis of the extracellular matrix: Implications for fibrotic diseases and cancer. Dis. Model Mech. 4, 165\u2013178. https:\/\/doi.org\/10.1242\/dmm.004077 (2011).","journal-title":"Dis. Model Mech."},{"key":"75233_CR18","doi-asserted-by":"publisher","first-page":"1277","DOI":"10.1001\/archneur.63.9.1277","volume":"63","author":"H Zetterberg","year":"2006","unstructured":"Zetterberg, H. et al. Neurochemical aftermath of amateur boxing. Arch. Neurol. 63, 1277\u20131280. https:\/\/doi.org\/10.1001\/archneur.63.9.1277 (2006).","journal-title":"Arch. Neurol."},{"key":"75233_CR19","doi-asserted-by":"publisher","first-page":"e33606","DOI":"10.1371\/journal.pone.0033606","volume":"7","author":"S Neselius","year":"2012","unstructured":"Neselius, S. et al. CSF-biomarkers in Olympic boxing: Diagnosis and effects of repetitive head trauma. PLoS ONE 7, e33606. https:\/\/doi.org\/10.1371\/journal.pone.0033606 (2012).","journal-title":"PLoS ONE"},{"key":"75233_CR20","doi-asserted-by":"publisher","first-page":"1457","DOI":"10.1212\/01.wnl.0000063313.57292.00","volume":"60","author":"G Franz","year":"2003","unstructured":"Franz, G. et al. Amyloid beta 1\u201342 and tau in cerebrospinal fluid after severe traumatic brain injury. Neurology 60, 1457\u20131461. https:\/\/doi.org\/10.1212\/01.wnl.0000063313.57292.00 (2003).","journal-title":"Neurology"},{"key":"75233_CR21","doi-asserted-by":"publisher","first-page":"131","DOI":"10.1016\/s0006-8993(02)02920-7","volume":"947","author":"FP Zemlan","year":"2002","unstructured":"Zemlan, F. P. et al. C-tau biomarker of neuronal damage in severe brain injured patients: Association with elevated intracranial pressure and clinical outcome. Brain Res. 947, 131\u2013139. https:\/\/doi.org\/10.1016\/s0006-8993(02)02920-7 (2002).","journal-title":"Brain Res."},{"key":"75233_CR22","doi-asserted-by":"publisher","first-page":"1600","DOI":"10.1212\/01.wnl.0000242732.06714.0f","volume":"67","author":"M Ost","year":"2006","unstructured":"Ost, M. et al. Initial CSF total tau correlates with 1-year outcome in patients with traumatic brain injury. Neurology 67, 1600\u20131604. https:\/\/doi.org\/10.1212\/01.wnl.0000242732.06714.0f (2006).","journal-title":"Neurology"},{"key":"75233_CR23","doi-asserted-by":"publisher","first-page":"946","DOI":"10.1089\/neu.2012.2579","volume":"30","author":"A Goyal","year":"2013","unstructured":"Goyal, A. et al. S100b as a prognostic biomarker in outcome prediction for patients with severe traumatic brain injury. J. Neurotrauma 30, 946\u2013957. https:\/\/doi.org\/10.1089\/neu.2012.2579 (2013).","journal-title":"J. Neurotrauma"},{"key":"75233_CR24","doi-asserted-by":"publisher","first-page":"E31","DOI":"10.1542\/peds.109.2.e31","volume":"109","author":"RP Berger","year":"2002","unstructured":"Berger, R. P. et al. Neuron-specific enolase and S100B in cerebrospinal fluid after severe traumatic brain injury in infants and children. Pediatrics 109, E31. https:\/\/doi.org\/10.1542\/peds.109.2.e31 (2002).","journal-title":"Pediatrics"},{"key":"75233_CR25","doi-asserted-by":"publisher","first-page":"e0132177","DOI":"10.1371\/journal.pone.0132177","volume":"10","author":"F Al Nimer","year":"2015","unstructured":"Al Nimer, F. et al. Comparative assessment of the prognostic value of biomarkers in traumatic brain injury reveals an independent role for serum levels of neurofilament light. PLoS ONE 10, e0132177. https:\/\/doi.org\/10.1371\/journal.pone.0132177 (2015).","journal-title":"PLoS ONE"},{"key":"75233_CR26","doi-asserted-by":"publisher","first-page":"36791","DOI":"10.1038\/srep36791","volume":"6","author":"P Shahim","year":"2016","unstructured":"Shahim, P. et al. Serum neurofilament light protein predicts clinical outcome in traumatic brain injury. Sci. Rep. 6, 36791. https:\/\/doi.org\/10.1038\/srep36791 (2016).","journal-title":"Sci. Rep."},{"key":"75233_CR27","doi-asserted-by":"publisher","first-page":"285","DOI":"10.1186\/s13054-016-1450-y","volume":"20","author":"EP Thelin","year":"2016","unstructured":"Thelin, E. P. et al. Utility of neuron-specific enolase in traumatic brain injury; relations to S100B levels, outcome, and extracranial injury severity. Crit. Care 20, 285. https:\/\/doi.org\/10.1186\/s13054-016-1450-y (2016).","journal-title":"Crit. Care"},{"key":"75233_CR28","doi-asserted-by":"publisher","first-page":"1786","DOI":"10.1212\/WNL.0b013e3181fd62d2","volume":"75","author":"PE Vos","year":"2010","unstructured":"Vos, P. E. et al. GFAP and S100B are biomarkers of traumatic brain injury: An observational cohort study. Neurology 75, 1786\u20131793. https:\/\/doi.org\/10.1212\/WNL.0b013e3181fd62d2 (2010).","journal-title":"Neurology"},{"key":"75233_CR29","doi-asserted-by":"publisher","first-page":"649","DOI":"10.1038\/nri3499","volume":"13","author":"R Khokha","year":"2013","unstructured":"Khokha, R., Murthy, A. & Weiss, A. Metalloproteinases and their natural inhibitors in inflammation and immunity. Nat. Rev. Immunol. 13, 649\u2013665. https:\/\/doi.org\/10.1038\/nri3499 (2013).","journal-title":"Nat. Rev. Immunol."},{"key":"75233_CR30","doi-asserted-by":"publisher","first-page":"156","DOI":"10.1177\/1073858409355830","volume":"16","author":"H Zhang","year":"2010","unstructured":"Zhang, H., Adwanikar, H., Werb, Z. & Noble-Haeusslein, L. J. Matrix metalloproteinases and neurotrauma: Evolving roles in injury and reparative processes. Neuroscientist 16, 156\u2013170. https:\/\/doi.org\/10.1177\/1073858409355830 (2010).","journal-title":"Neuroscientist"},{"key":"75233_CR31","doi-asserted-by":"publisher","first-page":"87","DOI":"10.1016\/j.nbd.2006.02.006","volume":"23","author":"KJ Gurney","year":"2006","unstructured":"Gurney, K. J., Estrada, E. Y. & Rosenberg, G. A. Blood\u2013brain barrier disruption by stromelysin-1 facilitates neutrophil infiltration in neuroinflammation. Neurobiol. Dis. 23, 87\u201396. https:\/\/doi.org\/10.1016\/j.nbd.2006.02.006 (2006).","journal-title":"Neurobiol. Dis."},{"key":"75233_CR32","doi-asserted-by":"publisher","first-page":"7724","DOI":"10.1523\/JNEUROSCI.21-19-07724.2001","volume":"21","author":"M Asahi","year":"2001","unstructured":"Asahi, M. et al. Effects of matrix metalloproteinase-9 gene knock-out on the proteolysis of blood\u2013brain barrier and white matter components after cerebral ischemia. J. Neurosci. 21, 7724\u20137732 (2001).","journal-title":"J. Neurosci."},{"key":"75233_CR33","doi-asserted-by":"publisher","first-page":"590","DOI":"10.1007\/s004010050754","volume":"94","author":"JA Cossins","year":"1997","unstructured":"Cossins, J. A. et al. Enhanced expression of MMP-7 and MMP-9 in demyelinating multiple sclerosis lesions. Acta Neuropathol. 94, 590\u2013598. https:\/\/doi.org\/10.1007\/s004010050754 (1997).","journal-title":"Acta Neuropathol."},{"key":"75233_CR34","doi-asserted-by":"publisher","first-page":"606","DOI":"10.4103\/0028-3886.125258","volume":"61","author":"K Zheng","year":"2013","unstructured":"Zheng, K. et al. Matrix metalloproteinases and their tissue inhibitors in serum and cerebrospinal fluid of patients with moderate and severe traumatic brain injury. Neurol. India 61, 606\u2013609. https:\/\/doi.org\/10.4103\/0028-3886.125258 (2013).","journal-title":"Neurol. India"},{"key":"75233_CR35","doi-asserted-by":"publisher","first-page":"702","DOI":"10.1227\/01.NEU.0000351768.11363.48","volume":"65","author":"M Grossetete","year":"2009","unstructured":"Grossetete, M., Phelps, J., Arko, L., Yonas, H. & Rosenberg, G. A. Elevation of matrix metalloproteinases 3 and 9 in cerebrospinal fluid and blood in patients with severe traumatic brain injury. Neurosurgery 65, 702\u2013708. https:\/\/doi.org\/10.1227\/01.NEU.0000351768.11363.48 (2009).","journal-title":"Neurosurgery"},{"key":"75233_CR36","doi-asserted-by":"publisher","first-page":"6106","DOI":"10.1007\/s12035-015-9520-8","volume":"53","author":"PM Abdul-Muneer","year":"2016","unstructured":"Abdul-Muneer, P. M., Pfister, B. J., Haorah, J. & Chandra, N. Role of matrix metalloproteinases in the pathogenesis of traumatic brain injury. Mol. Neurobiol. 53, 6106\u20136123. https:\/\/doi.org\/10.1007\/s12035-015-9520-8 (2016).","journal-title":"Mol. Neurobiol."},{"key":"75233_CR37","doi-asserted-by":"publisher","first-page":"2017","DOI":"10.1016\/j.bbamcr.2017.05.010","volume":"2036\u20132042","author":"B Fingleton","year":"1864","unstructured":"Fingleton, B. Matrix metalloproteinases as regulators of inflammatory processes. Biochim. Biophys. Acta Mol. Cell Res. 2036\u20132042, 2017. https:\/\/doi.org\/10.1016\/j.bbamcr.2017.05.010 (1864).","journal-title":"Biochim. Biophys. Acta Mol. Cell Res."},{"key":"75233_CR38","doi-asserted-by":"publisher","first-page":"279","DOI":"10.1002\/glia.10108","volume":"39","author":"GA Rosenberg","year":"2002","unstructured":"Rosenberg, G. A. Matrix metalloproteinases in neuroinflammation. Glia 39, 279\u2013291. https:\/\/doi.org\/10.1002\/glia.10108 (2002).","journal-title":"Glia"},{"key":"75233_CR39","first-page":"97","volume":"37","author":"K Akai","year":"1987","unstructured":"Akai, K., Uchigasaki, S., Tanaka, U. & Komatsu, A. Normal pressure hydrocephalus. Neuropathological study. Acta Pathol. Jpn. 37, 97\u2013110 (1987).","journal-title":"Acta Pathol. Jpn."},{"key":"75233_CR40","doi-asserted-by":"publisher","first-page":"1122","DOI":"10.1212\/wnl.50.4.1122","volume":"50","author":"M Tullberg","year":"1998","unstructured":"Tullberg, M., Rosengren, L., Blomsterwall, E., Karlsson, J. E. & Wikkelso, C. CSF neurofilament and glial fibrillary acidic protein in normal pressure hydrocephalus. Neurology 50, 1122\u20131127. https:\/\/doi.org\/10.1212\/wnl.50.4.1122 (1998).","journal-title":"Neurology"},{"key":"75233_CR41","doi-asserted-by":"publisher","first-page":"463","DOI":"10.1146\/annurev.cellbio.17.1.463","volume":"17","author":"MD Sternlicht","year":"2001","unstructured":"Sternlicht, M. D. & Werb, Z. How matrix metalloproteinases regulate cell behavior. Annu. Rev. Cell Dev. Biol. 17, 463\u2013516. https:\/\/doi.org\/10.1146\/annurev.cellbio.17.1.463 (2001).","journal-title":"Annu. Rev. Cell Dev. Biol."},{"key":"75233_CR42","doi-asserted-by":"publisher","first-page":"2089","DOI":"10.1161\/CIRCULATIONAHA.105.573865","volume":"113","author":"SH Ahmed","year":"2006","unstructured":"Ahmed, S. H. et al. Matrix metalloproteinases\/tissue inhibitors of metalloproteinases: Relationship between changes in proteolytic determinants of matrix composition and structural, functional, and clinical manifestations of hypertensive heart disease. Circulation 113, 2089\u20132096. https:\/\/doi.org\/10.1161\/CIRCULATIONAHA.105.573865 (2006).","journal-title":"Circulation"},{"key":"75233_CR43","doi-asserted-by":"publisher","first-page":"226","DOI":"10.1111\/j.1468-1331.2009.02775.x","volume":"17","author":"I Niebroj-Dobosz","year":"2010","unstructured":"Niebroj-Dobosz, I., Janik, P., Sokolowska, B. & Kwiecinski, H. Matrix metalloproteinases and their tissue inhibitors in serum and cerebrospinal fluid of patients with amyotrophic lateral sclerosis. Eur. J. Neurol. 17, 226\u2013231. https:\/\/doi.org\/10.1111\/j.1468-1331.2009.02775.x (2010).","journal-title":"Eur. J. Neurol."},{"key":"75233_CR44","doi-asserted-by":"publisher","first-page":"2010","DOI":"10.1016\/j.bbamcr.2010.01.003","volume":"55\u201371","author":"K Brew","year":"1803","unstructured":"Brew, K. & Nagase, H. The tissue inhibitors of metalloproteinases (TIMPs): An ancient family with structural and functional diversity. Biochim. Biophys. Acta 55\u201371, 2010. https:\/\/doi.org\/10.1016\/j.bbamcr.2010.01.003 (1803).","journal-title":"Biochim. Biophys. Acta"},{"key":"75233_CR45","doi-asserted-by":"publisher","first-page":"1905","DOI":"10.1110\/ps.072978507","volume":"16","author":"AB Hamze","year":"2007","unstructured":"Hamze, A. B. et al. Constraining specificity in the N-domain of tissue inhibitor of metalloproteinases-1; gelatinase-selective inhibitors. Protein Sci. 16, 1905\u20131913. https:\/\/doi.org\/10.1110\/ps.072978507 (2007).","journal-title":"Protein Sci."},{"key":"75233_CR46","doi-asserted-by":"publisher","first-page":"496","DOI":"10.1016\/j.expneurol.2006.12.012","volume":"204","author":"MA Pizzi","year":"2007","unstructured":"Pizzi, M. A. & Crowe, M. J. Matrix metalloproteinases and proteoglycans in axonal regeneration. Exp. Neurol. 204, 496\u2013511. https:\/\/doi.org\/10.1016\/j.expneurol.2006.12.012 (2007).","journal-title":"Exp. Neurol."},{"key":"75233_CR47","doi-asserted-by":"publisher","first-page":"38885","DOI":"10.1074\/jbc.M003875200","volume":"275","author":"H Nakamura","year":"2000","unstructured":"Nakamura, H. et al. Brevican is degraded by matrix metalloproteinases and aggrecanase-1 (ADAMTS4) at different sites. J. Biol. Chem. 275, 38885\u201338890. https:\/\/doi.org\/10.1074\/jbc.M003875200 (2000).","journal-title":"J. Biol. Chem."},{"key":"75233_CR48","doi-asserted-by":"publisher","first-page":"1080","DOI":"10.3389\/fneur.2018.01080","volume":"9","author":"M Castellazzi","year":"2018","unstructured":"Castellazzi, M. et al. Multiplex matrix metalloproteinases analysis in the cerebrospinal fluid reveals potential specific patterns in multiple sclerosis patients. Front. Neurol. 9, 1080. https:\/\/doi.org\/10.3389\/fneur.2018.01080 (2018).","journal-title":"Front. Neurol."},{"key":"75233_CR49","doi-asserted-by":"publisher","first-page":"1565","DOI":"10.1515\/cclm-2019-0034","volume":"57","author":"K Minta","year":"2019","unstructured":"Minta, K. et al. Dynamics of extracellular matrix proteins in cerebrospinal fluid and serum and their relation to clinical outcome in human traumatic brain injury. Clin. Chem. Lab. Med. 57, 1565\u20131573. https:\/\/doi.org\/10.1515\/cclm-2019-0034 (2019).","journal-title":"Clin. Chem. Lab. Med."},{"key":"75233_CR50","doi-asserted-by":"publisher","first-page":"2850","DOI":"10.1089\/neu.2019.6375","volume":"36","author":"E Thelin","year":"2019","unstructured":"Thelin, E. et al. A serum protein biomarker panel improves outcome prediction in human traumatic brain injury. J. Neurotrauma 36, 2850\u20132862. https:\/\/doi.org\/10.1089\/neu.2019.6375 (2019).","journal-title":"J. Neurotrauma"},{"key":"75233_CR51","doi-asserted-by":"publisher","first-page":"1638","DOI":"10.1097\/TA.0b013e3181744b03","volume":"64","author":"JB Kortbeek","year":"2008","unstructured":"Kortbeek, J. B. et al. Advanced trauma life support, 8th edition, the evidence for change. J. Trauma 64, 1638\u20131650. https:\/\/doi.org\/10.1097\/TA.0b013e3181744b03 (2008).","journal-title":"J. Trauma"}],"container-title":["Scientific Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41598-020-75233-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-020-75233-z","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-020-75233-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,12,6]],"date-time":"2022-12-06T16:47:00Z","timestamp":1670345220000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41598-020-75233-z"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,10,22]]},"references-count":51,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2020,12]]}},"alternative-id":["75233"],"URL":"https:\/\/doi.org\/10.1038\/s41598-020-75233-z","relation":{},"ISSN":["2045-2322"],"issn-type":[{"value":"2045-2322","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,10,22]]},"assertion":[{"value":"2 May 2020","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"7 October 2020","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"22 October 2020","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"HZ has served at scientific advisory boards for Denali, Roche Diagnostics, Wave, Samumed and CogRx, has given lectures in symposia sponsored by Fujirebio, Alzecure and Biogen, and is a co-founder of Brain Biomarker Solutions in Gothenburg AB (BBS), which is a part of the GU Ventures Incubator Program. KB has served as a consultant or at advisory boards for Abcam, Axon, Biogen, Lilly, MagQu, Novartis and Roche Diagnostics, and is a co-founder of Brain Biomarker Solutions in Gothenburg AB (BBS), which is a part of the GU Ventures Incubator Program. KM, GB, EP, FP, EPT, AJ, MT, FN and UA declare that they have no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"18075"}}